-transparent.png){kind=logo}
A survey for West Nile Complement Fixing (CF) antibody was carried out in humans and domestic animals in Nigeria. Human sera were obtained from two communities namely Ibadan and Ogbomoso but animal sera were collected from Ibadan and Maiduguri. The overall CF antibody to West Nile virus in the two localities surveyed was 65%. Of 170 persons tested, 53% and 75% were positive in Ibadan and Ogbomoso respectively. Antibody prevalence increased with age in both communities. Tests for antibody against other flaviviruses revealed that monotypic complement fixation reactions were found frequently in young people, but broadly reacting sera were common among the older age groups. Sex distribution of West Nile CF antibody showed that 49/82 (60%) of females and 62/88 (75%) of males had West Nile CF antibody. Tests on animal sera showed that 33% contained CF antibody to West Nile virus. Prevalence of CF antibody in different animal species was 62% in camels, 4% in cattle and 0% in goats.
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
June 1963,
Revue neurologique,
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
September 2004,
Comparative immunology, microbiology and infectious diseases,
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
September 1975,
Acta virologica,
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
June 1963,
Revue neurologique,
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
October 2010,
Vector borne and zoonotic diseases (Larchmont, N.Y.),
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
October 2009,
Vector borne and zoonotic diseases (Larchmont, N.Y.),
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
June 1956,
Zeitschrift fur Immunitatsforschung und experimentelle Therapie,
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
May 2016,
Vector borne and zoonotic diseases (Larchmont, N.Y.),
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
January 2020,
Pathogens (Basel, Switzerland),
S A Omilabu, and
O D Olaleye, and
Y Aina, and
A H Fagbami
December 2019,
Emerging infectious diseases,
